An interventional study of Active de-Implementation in Breast Lumpectomy, Laparoscopic Cholecystectomy and Inguinal Hernia Repair, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.
Sponsored by University of Michigan · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 77 studies in Hernia, Inguinal with a site in United States — 9 open to participants now, 20 under way, none of them phase 3. Hernia, Inguinal · United States.
Among the 77 studies in Hernia, Inguinal with a site in United States, this one is the 57th largest by planned enrollment of the 60 interventional ones that give a count, is one of 3 that started in 2025, is one of 36 with no phase, reaches primary completion later than 9 of the 19 other live ones, and was the 71st registered.
545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.
Browse Hernia, Inguinal studies →9 of the 77 studies in Hernia, Inguinal with a site in United States are open now. Recruiting first, the newest first:
Northwestern University · Sites in United States
Ages 18+
Northwestern University · Sites in United States
Ages 50+ · Men only
Northwestern University · Sites in United States
Ages 18+
Distalmotion SA · Sites in United States
Ages 22+
VA Eastern Colorado Health Care System · Sites in United States
Ages 18–99 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
77 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 7 · Phase 3 7 · Phase 4 10
First in 1987; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 16 is below the median of 90 across 397 interventional studies indexed under Hernia, Inguinal.
Median enrollment 100 across the 60 interventional studies, 116 across the 17 observational. Of the 50 that completed or were terminated, 24 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
30 of 77 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,509 studies on the registry; 194 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 134 (79%) have results posted.
University of Michigan has 1 study filed under Hernia, Inguinal — fewer than ten, so there is no comparison to draw.
4 of the studies in Hernia, Inguinal with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06934564University of MichiganDe-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery | 2026-12 |
| NCT04779918Tela Bio IncVentral or Inguinal Hernia, Robotically Repaired With OviTex Mesh | 2027-03-30 |
| NCT05388929Prisma Health-UpstateMethocarbamol in Ventral and Inguinal HR | 2027-06 |
| NCT05929937Clayton PetroNo Opioids vs. Minimal Opioids Following Inguinal Hernia Repair | 2027-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 77 studies in Hernia, Inguinal with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Site
Inclusion Criteria:
Exclusion Criteria:
Surgical participants must be over 18 years old.
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 2
Behavioral: Active de-Implementation
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 3
Behavioral: Active de-Implementation
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 1 Quarter 4
Behavioral: Active de-Implementation
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 1
Behavioral: Active de-Implementation
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 2
Behavioral: Active de-Implementation
Each wave will include usual care, preparation (8 weeks before intervention), active de-implementation interventions, and sustainment phases. Intervention is Year 2 Quarter 3
Behavioral: Active de-Implementation
During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.
Number of tests within 30 days of surgery not associated with an emergency department visit
Only tests relating to three index procedures; breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair Data collected using MVC/MSQC database
Time frame: Within 30 days of surgery
Number of unnecessary preoperative testing before low-risk surgery at MVC/MSQC sites not participating in the trial
Example related operations: laparoscopic hysterectomy, knee arthroscopy
Time frame: Up to year 2, quarter 4
30-day episode-based spending
Using the MVC claims data for total spending amounts
Time frame: Up to Year 2, Quarter 2
Number of unnecessary preoperative testing before low-risk surgery at trial sites
Example related operations: laparoscopic hysterectomy, knee arthroscopy
Time frame: Up to year 2, quarter 4
Number of intraoperative complications
Examples: myocardial infarction, stroke
Time frame: Up to year 2, quarter 4
Number of same-day case cancellations
Time frame: Up to year 2, quarter 4
Started Apr 2025 (actual). Primary completion is estimated for Dec 2026, 20 months after the start.
Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 20 months is close to that.
Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.